Maven Securities »

Sionna Therapeutics shares owned by Maven Securities

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by Maven Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0M 25k 40.09

More positions owned by Maven Securities

State Str Spdr S&p 500 Et F T Put
Invesco Qqq Tr Call Call Option
State Str Spdr S&p 500 Et F T Call
State Str Spdr S&p 500 E Tf T Tr Unit (SPY)
Invesco Qqq Tr Put Put Option
Select Sector Spdr Tr Call Call Option
Select Sector Spdr Tr Put Put Option
Amazon Put Put Option
Advanced Micro Devices In C Put
Meta Platforms Call Call Option
Newmont Corp Put Put Option
Exxon Mobil Corp Put Put Option
Microsoft Corp Put Put Option
Unitedhealth Group Put Put Option
Ishares Tr Call Call Option

View all positions for Maven Securities

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
OrbiMed Advisors
Viking Global Investors
Atlas Venture Life Science Advisors
Enavate Sciences GP
Jennison Associates
BlackRock
Citadel Advisors
Vanguard Capital Management
Deerfield Management Company
State Street Corporation
Perceptive Advisors
Eventide Asset Management
Standard Life Aberdeen

View all funds holding Sionna Therapeutics